At a glance
ClinicalIndex Comparison RecordN/ACompleted· 664 enrolled
Drug / intervention
SRS 2, CBCL, BRIEF-Pother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)
In Brief
An observational study evaluating SRS 2, CBCL, BRIEF-P for Autism Spectrum Disorder and 6 related conditions. Completed, enrolled 664 participants across 58 sites in 4 countries.
Detailed Summary
FACT 4 Child is a follow up study of mothers who participated in the Folic Acid Clinical Trial (NCT01355159) and their children at 4-6 years of age to determine the effect of high dose folic acid supplementation on social impairments associated with Autism Spectrum Disorders (ASDs), and deficiencies in a range of executive function and emotional and behavioural problems in young children, and the risk of death.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAutism Spectrum Disorder, Asthma, Executive Dysfunction, Emotional Problem, Behavioural Problem, Pre-Eclampsia, Death
CountriesAustralia, Canada, Jamaica, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedAug 2017
Primary CompletionDec 2023
TodayJul 2026
First PostedAug 31, 2017
Enrollment StartJul 1, 2017
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 8.8 years ago
Interventions
SRS 2, CBCL, BRIEF-Pother
This study does not involve an intervention.